Sadeghi Mohammad Bagher, Nakhaee Alireza, Saravani Ramin, Sargazi Saman
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
J Diabetes Metab Disord. 2021 Jan 27;20(1):261-270. doi: 10.1007/s40200-021-00740-3. eCollection 2021 Jun.
To investigate if single-nucleotide polymorphisms (SNPs) in the gene encoding contribute to the development of type-2 diabetes mellitus (T2DM) and whether genotypes of two polymorphisms, rs28514894 and rs2303044, are associated with laboratory characteristics of T2DM patients.
A total of 900 subjects (450 T2DM cases and 450 healthy subjects) of Iranian ancestry were genotyped for polymorphisms via ARMS-PCR and PCR-RFLP techniques.
Our findings showed a significant correlation between both polymorphisms and increased risk of T2DM. The haplotype analysis showed an association between the C A haplotype with enhanced risk of T2DM. In T2DM patients, the mean level of HbA1C and BUN significantly differed among carriers of CC and TT genotypes of the rs28514894 polymorphism ( = 0.05 and < 0.0001, respectively); while in the control group, no significant difference was noticed between subjects with these genotypes. The mean BUN levels also significantly differed among carriers of TC and TT genotypes of this variant in T2DM patients ( = 0.01) and controls ( = 0.04). As for rs2303044 polymorphism, only the mean BUN level significantly differed between GA and GG carriers in T2DM patients ( = 0.006). Compared with CT and TT genotypes, the CC genotype of rs28514894 polymorphism was more frequent in overweight T2DM patients ( 25 < body mass index < 30).
The present research provided the first documents of the correlation of rs28514894 and rs2303044 polymorphisms with susceptibility to T2DM. Replicated case-control studies on larger populations are needed to validate these findings.
研究编码基因中的单核苷酸多态性(SNP)是否有助于2型糖尿病(T2DM)的发生发展,以及两种多态性rs28514894和rs2303044的基因型是否与T2DM患者的实验室特征相关。
通过扩增阻滞突变系统聚合酶链反应(ARMS-PCR)和聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,对900名具有伊朗血统的受试者(450例T2DM患者和450名健康受试者)进行多态性基因分型。
我们的研究结果表明,这两种多态性均与T2DM风险增加显著相关。单倍型分析显示,C A单倍型与T2DM风险增加有关。在T2DM患者中,rs28514894多态性的CC和TT基因型携带者之间,糖化血红蛋白(HbA1C)和尿素氮(BUN)的平均水平存在显著差异(分别为P = 0.05和P < 0.0001);而在对照组中,这些基因型的受试者之间未观察到显著差异。在T2DM患者(P = 0.01)和对照组(P = 0.04)中,该变体的TC和TT基因型携带者之间的平均BUN水平也存在显著差异。至于rs2303044多态性,仅T2DM患者中GA和GG携带者之间的平均BUN水平存在显著差异(P = 0.006)。与CT和TT基因型相比,rs28514894多态性的CC基因型在超重T2DM患者(体重指数25 < 体重指数 < 30)中更为常见。
本研究首次提供了rs28514894和rs2303044多态性与T2DM易感性相关性的文献资料。需要在更大规模人群中进行重复的病例对照研究以验证这些发现。